{"id":41224,"date":"2026-09-23T10:35:53","date_gmt":"2026-09-23T05:05:53","guid":{"rendered":"https:\/\/mdforlives.com\/blog\/?p=41224"},"modified":"2026-10-01T22:33:42","modified_gmt":"2026-10-01T17:03:42","slug":"oncology-innovation","status":"publish","type":"post","link":"https:\/\/mdforlives.com\/blog\/oncology-innovation\/","title":{"rendered":"The Other Side of Oncology Innovation: Why Progress Still Feels Uneven in Practice\u00a0"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"41224\" class=\"elementor elementor-41224\" data-elementor-post-type=\"post\">\n\t\t\t\t<div class=\"elementor-element elementor-element-5ff00724 e-con-full e-flex e-con e-parent\" data-id=\"5ff00724\" data-element_type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-403a84c8 elementor-widget elementor-widget-text-editor\" data-id=\"403a84c8\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div class=\"post-heading\"><div class=\"categ\"><p><span data-contrast=\"auto\">Oncology has never had more tools to personalize care.<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p><p><span data-contrast=\"auto\">Biomarker testing can refine treatment selection. Immunotherapy can produce meaningful responses in selected patients. AI can support diagnostics, workflows, and decision-making. The direction of progress is undeniable.<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p><p><span data-contrast=\"auto\">But inside real-world oncology practice, innovation does not always arrive as a clean breakthrough. It arrives with eligibility questions, reimbursement delays, biomarker reports that do not always change management, immune-related toxicity, uncertain patient selection, and AI tools that still need validation before clinicians can rely on them.<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p><p><span data-contrast=\"auto\">That is the other side of oncology innovation.<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p><p><span data-contrast=\"auto\">The MDForLives oncology survey data shows a practical tension: innovation is changing decisions and discussions, but its real-world delivery remains uneven. Among oncology clinicians who responded, the strongest pattern is not rejection of progress. It is calibrated realism.<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p><h2><b><span data-contrast=\"auto\">Innovation Is Changing Practice, but Not Always Outcomes<\/span><\/b><span data-ccp-props=\"{}\">\u00a0<\/span><\/h2><p><span data-contrast=\"auto\">The survey data suggests that oncologists see meaningful movement, but not uniform transformation. When asked how oncology innovation is shaping practice today, 31.3% said it is changing decisions more than outcomes so far, and another 31.3% said it is changing discussions more than actual management. Only 25.0% said it is clearly changing patient outcomes and clinical decisions.<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p><p><span data-contrast=\"auto\">That distinction matters.<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p><p><span data-contrast=\"auto\">A new test, therapy, or AI tool can change the conversation before it changes the outcome. It can introduce a treatment possibility, refine a tumor board discussion, support a referral, or raise a question about eligibility. But that does not always translate into a different treatment path for the patient in front of the clinician.<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p><p><span data-contrast=\"auto\">This is where oncology innovation becomes more complex than its headline promise. The field is moving quickly. Routine care moves through evidence, access, workflows, and patient-specific constraints<\/span><span data-contrast=\"auto\">.<\/span><\/p><blockquote><p>New oncology platforms can move from clinical promise to real-world use faster than confidence and evidence can develop. Explore how <span style=\"color: #004c97;\"><a class=\"decorated-link\" style=\"color: #004c97;\" href=\"https:\/\/mdforlives.com\/blog\/adcs-in-oncology\/\" target=\"_blank\" rel=\"noopener\" data-start=\"859\" data-end=\"955\">ADCs in oncology<\/a><\/span> are navigating this gap between innovation and clinical practice.<\/p><\/blockquote><h2><b><span data-contrast=\"auto\">Precision Oncology Still Faces the Actionability Gap<\/span><\/b><span data-ccp-props=\"{}\">\u00a0<\/span><\/h2><p><span data-contrast=\"auto\">Precision oncology is one of the clearest examples of this gap. Biomarker testing is increasingly central to treatment selection, but testing does not always produce an actionable decision.<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p><p><span data-contrast=\"auto\">In the MDForLives survey data, 48.6% cited cost and reimbursement barriers as a limitation in implementing precision oncology. Another 42.9% pointed to few actionable alterations despite testing, while 28.6% cited unclear treatment value in some settings.<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p><p><span data-contrast=\"auto\">The most revealing finding is what happens after testing: 37.1% said genomic or biomarker findings frequently fail to translate into actionable treatment decisions, and 54.3% said this happens sometimes.<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p><p><span data-contrast=\"auto\">That means the issue is not whether testing matters. It does. The issue is whether the test result can be connected to an accessible, evidence-supported, clinically appropriate treatment pathway.<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p><p><span data-contrast=\"auto\">For many oncologists, the challenge is not information. It is conversion: turning molecular insight into a decision that is possible, funded, timely, and meaningful.<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p><blockquote><p>The value of precision oncology depends on whether molecular findings can lead to meaningful treatment decisions. Explore <span style=\"color: #004c97;\"><a class=\"decorated-link\" style=\"color: #004c97;\" href=\"https:\/\/mdforlives.com\/blog\/targeted-therapy-for-cancer\/\" target=\"_blank\" rel=\"noopener\" data-start=\"1862\" data-end=\"1969\">targeted therapy for cancer<\/a><\/span> and how treatment options are evolving.<\/p><\/blockquote><h2><b><span data-contrast=\"auto\">Immunotherapy Has Changed Expectations, but Prediction Remains Hard<\/span><\/b><span data-ccp-props=\"{}\">\u00a0<\/span><\/h2><p><span data-contrast=\"auto\">Immunotherapy has reshaped oncology across multiple tumor types. But it has also created one of the hardest questions in modern cancer care: who will benefit?<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p><p><span data-contrast=\"auto\">The survey data shows that confidence remains measured. Only 14.7% of respondents said they are highly confident in predicting which patients will benefit from immunotherapy. Most, 58.8%, reported moderate confidence, while 17.6% were slightly confident and 8.8% were not confident.<\/span><\/p><blockquote><p>The expansion of immunotherapy has made patient selection an increasingly important part of cancer care. Explore how patients and clinicians navigate <a href=\"https:\/\/mdforlives.com\/blog\/immunotherapy\/\" target=\"_blank\" rel=\"noopener\"><span style=\"color: #004c97;\">precision cancer care and immunotherapy decisions.<\/span><\/a><\/p><\/blockquote><p><span data-contrast=\"auto\">The main limitation was not a single issue. Immune-related adverse events led at 32.4%, followed closely by high cost and access issues at 29.4%, and limited efficacy in certain tumor types at 23.5%.<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p><p><span data-contrast=\"auto\">This creates a dual burden. Immunotherapy can offer significant benefit, but clinicians must balance that possibility against toxicity, cost, eligibility, tumor biology, and uncertainty in response prediction.<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p><p><span data-contrast=\"auto\">Oncology innovation often expands options. It does not remove the need for careful selection.<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p><h2><b><span data-contrast=\"auto\">AI Is Useful, but Still Narrow in Workflow Impact<\/span><\/b><span data-ccp-props=\"{}\">\u00a0<\/span><\/h2><p><span data-contrast=\"auto\">AI in oncology is attracting intense attention, but the survey data suggests its real-world usefulness remains selective. While 18.2% rated AI tools as highly useful and integrated, 60.6% said AI is useful only in limited scenarios. Another 12.1% said it is not useful in current practice.<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p><p><span data-contrast=\"auto\">The barriers help explain why. Limited validation in real-world settings was selected by 51.5%, followed by lack of trust in outputs or black-box nature at 36.4%, and integration challenges with existing systems at 36.4%.<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p><p><span data-contrast=\"auto\">This is not resistance to AI. It is a demand for clinical reliability.<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p><p><span data-contrast=\"auto\">Oncology workflows are high-stakes and information-heavy. If AI cannot integrate into existing systems, explain its outputs, perform reliably in routine settings, and support rather than complicate clinician judgment, its value remains constrained.<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p><p><span data-contrast=\"auto\">The signal from the survey data is clear: AI is promising, but oncology practice needs validation before scale.<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p><h2><b><span data-contrast=\"auto\">The Main Tension Is Evidence Versus Adoption Speed<\/span><\/b><span data-ccp-props=\"{}\">\u00a0<\/span><\/h2><p><img fetchpriority=\"high\" decoding=\"async\" class=\"aligncenter size-full wp-image-41346\" src=\"https:\/\/mdforlives.com\/blog\/wp-content\/uploads\/2026\/09\/The-Other-Side-of-Oncology-Innovation_Inner1.png\" alt=\"oncology innovation infographic showing uneven evidence cost access barriers and workflow gaps limiting real-world impact\" width=\"801\" height=\"400\" srcset=\"https:\/\/mdforlives.com\/blog\/wp-content\/uploads\/2026\/09\/The-Other-Side-of-Oncology-Innovation_Inner1.png 801w, https:\/\/mdforlives.com\/blog\/wp-content\/uploads\/2026\/09\/The-Other-Side-of-Oncology-Innovation_Inner1-300x150.png 300w, https:\/\/mdforlives.com\/blog\/wp-content\/uploads\/2026\/09\/The-Other-Side-of-Oncology-Innovation_Inner1-768x384.png 768w\" sizes=\"(max-width: 801px) 100vw, 801px\" \/><\/p><p><span data-contrast=\"auto\">When asked what tension most shapes real-world use of innovative oncology approaches, 37.5% selected faster adoption versus stronger evidence. Another 25.0% selected innovation versus equitable access, and 21.9% selected clinical benefit versus cost burden.<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p><p><span data-contrast=\"auto\">This is one of the strongest insights in the survey.<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p><p><span data-contrast=\"auto\">Oncologists are not only evaluating science. They are navigating timing. Adopt too slowly, and patients may miss meaningful options. Adopt too quickly, and practice may move ahead of evidence, infrastructure, reimbursement, or safety confidence.<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p><p><span data-contrast=\"auto\">Across precision medicine, immunotherapy, and AI, the biggest limiting factors were uneven evidence in routine care and cost and access barriers, each selected by 34.4%. Workflow and infrastructure gaps followed at 25.0%.<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p><p><span data-contrast=\"auto\">That makes the real limitation broader than any one innovation. Oncology innovation is being slowed by the systems required to deliver it consistently.<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p><h2><b><span data-contrast=\"auto\">What the Open Responses Add<\/span><\/b><span data-ccp-props=\"{}\">\u00a0<\/span><\/h2><p><span data-contrast=\"auto\">Open-ended responses in the survey data reinforced the same pattern. Clinicians pointed to access, cost, adverse events, time constraints, better clinical integration, training, delayed diagnosis, inclusion of people of color, and the need to know which patients truly benefit from personalized therapies.<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p><p><span data-contrast=\"auto\">These responses show that the next phase of progress is not only technical. It is operational, equitable, and practical.<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p><p><span data-contrast=\"auto\">The future of oncology innovation will depend on whether advanced tools can become usable in the settings where most patients are treated, not only in ideal environments.<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p><h2><b><span data-contrast=\"auto\">Closing Perspective<\/span><\/b><span data-ccp-props=\"{}\">\u00a0<\/span><\/h2><p><span data-contrast=\"auto\">The MDForLives survey data does not suggest that innovation is failing oncology.<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p><p><span data-contrast=\"auto\">It suggests something more useful: oncology innovation is entering a maturity phase.<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p><p><span data-contrast=\"auto\">The question is no longer whether precision medicine, immunotherapy, and AI can change cancer care. They already are. The question is whether they can do so consistently, affordably, safely, and with enough evidence to support real-world decisions.<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p><p><span data-contrast=\"auto\">For oncologists, the promise is real. So are the constraints.<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p><p><span data-contrast=\"auto\">The next step is not more innovation alone. It is better translation: from biomarker to action, from immunotherapy possibility to patient selection, from AI output to trusted workflow, and from breakthrough science to equitable delivery.<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p><p><span data-contrast=\"auto\">That is where the other side of oncology innovation becomes the next frontier.<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p><\/div><\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-b431c31 elementor-widget elementor-widget-heading\" data-id=\"b431c31\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Frequently Asked Questions<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-25d4a7b elementor-widget elementor-widget-n-accordion\" data-id=\"25d4a7b\" data-element_type=\"widget\" data-settings=\"{&quot;default_state&quot;:&quot;expanded&quot;,&quot;max_items_expended&quot;:&quot;one&quot;,&quot;n_accordion_animation_duration&quot;:{&quot;unit&quot;:&quot;ms&quot;,&quot;size&quot;:400,&quot;sizes&quot;:[]}}\" data-widget_type=\"nested-accordion.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"e-n-accordion\" aria-label=\"Accordion. Open links with Enter or Space, close with Escape, and navigate with Arrow Keys\">\n\t\t\t\t\t\t<details id=\"e-n-accordion-item-3960\" class=\"e-n-accordion-item\" open>\n\t\t\t\t<summary class=\"e-n-accordion-item-title\" data-accordion-index=\"1\" tabindex=\"0\" aria-expanded=\"true\" aria-controls=\"e-n-accordion-item-3960\" >\n\t\t\t\t\t<span class='e-n-accordion-item-title-header'><div class=\"e-n-accordion-item-title-text\"> What is oncology innovation?  <\/div><\/span>\n\t\t\t\t\t\t\t<span class='e-n-accordion-item-title-icon'>\n\t\t\t<span class='e-opened' ><i aria-hidden=\"true\" class=\"fas fa-angle-up\"><\/i><\/span>\n\t\t\t<span class='e-closed'><i aria-hidden=\"true\" class=\"fas fa-angle-down\"><\/i><\/span>\n\t\t<\/span>\n\n\t\t\t\t\t\t<\/summary>\n\t\t\t\t<div role=\"region\" aria-labelledby=\"e-n-accordion-item-3960\" class=\"elementor-element elementor-element-5441838 e-con-full e-flex e-con e-child\" data-id=\"5441838\" data-element_type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-6ee2459 elementor-widget elementor-widget-text-editor\" data-id=\"6ee2459\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><span class=\"TextRun SCXW70579014 BCX8\" lang=\"EN-IN\" xml:lang=\"EN-IN\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW70579014 BCX8\">Oncology innovation refers to advances such as precision medicine, biomarker testing, immunotherapy, AI-enabled tools, targeted therapies, and new care models that aim to improve cancer diagnosis, treatment selection, and outcomes.<\/span><\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/details>\n\t\t\t\t\t\t<details id=\"e-n-accordion-item-3961\" class=\"e-n-accordion-item\" >\n\t\t\t\t<summary class=\"e-n-accordion-item-title\" data-accordion-index=\"2\" tabindex=\"-1\" aria-expanded=\"false\" aria-controls=\"e-n-accordion-item-3961\" >\n\t\t\t\t\t<span class='e-n-accordion-item-title-header'><div class=\"e-n-accordion-item-title-text\"> Why does precision oncology not always lead to actionable treatment decisions? <\/div><\/span>\n\t\t\t\t\t\t\t<span class='e-n-accordion-item-title-icon'>\n\t\t\t<span class='e-opened' ><i aria-hidden=\"true\" class=\"fas fa-angle-up\"><\/i><\/span>\n\t\t\t<span class='e-closed'><i aria-hidden=\"true\" class=\"fas fa-angle-down\"><\/i><\/span>\n\t\t<\/span>\n\n\t\t\t\t\t\t<\/summary>\n\t\t\t\t<div role=\"region\" aria-labelledby=\"e-n-accordion-item-3961\" class=\"elementor-element elementor-element-9ffac9e e-con-full e-flex e-con e-child\" data-id=\"9ffac9e\" data-element_type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-d8a68dc elementor-widget elementor-widget-text-editor\" data-id=\"d8a68dc\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><span class=\"NormalTextRun SCXW221426173 BCX8\">Biomarker testing may <\/span><span class=\"NormalTextRun SCXW221426173 BCX8\">identify<\/span><span class=\"NormalTextRun SCXW221426173 BCX8\"> results that do not match an available therapy, are not reimbursed, lack clear treatment value, or require further interpretation before changing management.<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/details>\n\t\t\t\t\t\t<details id=\"e-n-accordion-item-3962\" class=\"e-n-accordion-item\" >\n\t\t\t\t<summary class=\"e-n-accordion-item-title\" data-accordion-index=\"3\" tabindex=\"-1\" aria-expanded=\"false\" aria-controls=\"e-n-accordion-item-3962\" >\n\t\t\t\t\t<span class='e-n-accordion-item-title-header'><div class=\"e-n-accordion-item-title-text\"> What limits immunotherapy use in real-world oncology practice? <\/div><\/span>\n\t\t\t\t\t\t\t<span class='e-n-accordion-item-title-icon'>\n\t\t\t<span class='e-opened' ><i aria-hidden=\"true\" class=\"fas fa-angle-up\"><\/i><\/span>\n\t\t\t<span class='e-closed'><i aria-hidden=\"true\" class=\"fas fa-angle-down\"><\/i><\/span>\n\t\t<\/span>\n\n\t\t\t\t\t\t<\/summary>\n\t\t\t\t<div role=\"region\" aria-labelledby=\"e-n-accordion-item-3962\" class=\"elementor-element elementor-element-95847b8 e-con-full e-flex e-con e-child\" data-id=\"95847b8\" data-element_type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-83a3ce2 elementor-widget elementor-widget-text-editor\" data-id=\"83a3ce2\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><span class=\"NormalTextRun SCXW116102165 BCX8\">Key limitations include immune-related adverse events, <\/span><span class=\"NormalTextRun SCXW116102165 BCX8\">high cost<\/span><span class=\"NormalTextRun SCXW116102165 BCX8\">, access issues, limited efficacy in certain <\/span><span class=\"NormalTextRun SpellingErrorV2Themed SCXW116102165 BCX8\">tumor<\/span><span class=\"NormalTextRun SCXW116102165 BCX8\"> types, and difficulty predicting which patients will benefit.<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/details>\n\t\t\t\t\t\t<details id=\"e-n-accordion-item-3963\" class=\"e-n-accordion-item\" >\n\t\t\t\t<summary class=\"e-n-accordion-item-title\" data-accordion-index=\"4\" tabindex=\"-1\" aria-expanded=\"false\" aria-controls=\"e-n-accordion-item-3963\" >\n\t\t\t\t\t<span class='e-n-accordion-item-title-header'><div class=\"e-n-accordion-item-title-text\"> Is AI useful in oncology practice today? <\/div><\/span>\n\t\t\t\t\t\t\t<span class='e-n-accordion-item-title-icon'>\n\t\t\t<span class='e-opened' ><i aria-hidden=\"true\" class=\"fas fa-angle-up\"><\/i><\/span>\n\t\t\t<span class='e-closed'><i aria-hidden=\"true\" class=\"fas fa-angle-down\"><\/i><\/span>\n\t\t<\/span>\n\n\t\t\t\t\t\t<\/summary>\n\t\t\t\t<div role=\"region\" aria-labelledby=\"e-n-accordion-item-3963\" class=\"elementor-element elementor-element-f29a337 e-con-full e-flex e-con e-child\" data-id=\"f29a337\" data-element_type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-80c42d3 elementor-widget elementor-widget-text-editor\" data-id=\"80c42d3\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><span class=\"NormalTextRun SCXW62874148 BCX8\">The <\/span><span class=\"NormalTextRun SpellingErrorV2Themed SCXW62874148 BCX8\">MDForLives<\/span><span class=\"NormalTextRun SCXW62874148 BCX8\"> survey data suggests AI is useful in limited scenarios for many clinicians, but broader use is limited by real-world validation, workflow integration, trust, and transparency.<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/details>\n\t\t\t\t\t\t<details id=\"e-n-accordion-item-3964\" class=\"e-n-accordion-item\" >\n\t\t\t\t<summary class=\"e-n-accordion-item-title\" data-accordion-index=\"5\" tabindex=\"-1\" aria-expanded=\"false\" aria-controls=\"e-n-accordion-item-3964\" >\n\t\t\t\t\t<span class='e-n-accordion-item-title-header'><div class=\"e-n-accordion-item-title-text\"> What is the biggest real-world tension in oncology innovation? <\/div><\/span>\n\t\t\t\t\t\t\t<span class='e-n-accordion-item-title-icon'>\n\t\t\t<span class='e-opened' ><i aria-hidden=\"true\" class=\"fas fa-angle-up\"><\/i><\/span>\n\t\t\t<span class='e-closed'><i aria-hidden=\"true\" class=\"fas fa-angle-down\"><\/i><\/span>\n\t\t<\/span>\n\n\t\t\t\t\t\t<\/summary>\n\t\t\t\t<div role=\"region\" aria-labelledby=\"e-n-accordion-item-3964\" class=\"elementor-element elementor-element-4727f24 e-con-full e-flex e-con e-child\" data-id=\"4727f24\" data-element_type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-62a1fc3 elementor-widget elementor-widget-text-editor\" data-id=\"62a1fc3\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><span class=\"TextRun SCXW24850732 BCX8\" lang=\"EN-IN\" xml:lang=\"EN-IN\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW24850732 BCX8\">The leading tension is faster adoption versus stronger evidence. Oncologists are balancing the urgency to use new tools with the need for reliable data and safe implementation.<\/span><\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/details>\n\t\t\t\t\t\t<details id=\"e-n-accordion-item-3965\" class=\"e-n-accordion-item\" >\n\t\t\t\t<summary class=\"e-n-accordion-item-title\" data-accordion-index=\"6\" tabindex=\"-1\" aria-expanded=\"false\" aria-controls=\"e-n-accordion-item-3965\" >\n\t\t\t\t\t<span class='e-n-accordion-item-title-header'><div class=\"e-n-accordion-item-title-text\"> What needs to change for oncology innovation to improve outcomes more consistently? <\/div><\/span>\n\t\t\t\t\t\t\t<span class='e-n-accordion-item-title-icon'>\n\t\t\t<span class='e-opened' ><i aria-hidden=\"true\" class=\"fas fa-angle-up\"><\/i><\/span>\n\t\t\t<span class='e-closed'><i aria-hidden=\"true\" class=\"fas fa-angle-down\"><\/i><\/span>\n\t\t<\/span>\n\n\t\t\t\t\t\t<\/summary>\n\t\t\t\t<div role=\"region\" aria-labelledby=\"e-n-accordion-item-3965\" class=\"elementor-element elementor-element-0f9e7e6 e-con-full e-flex e-con e-child\" data-id=\"0f9e7e6\" data-element_type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-85b8c7d elementor-widget elementor-widget-text-editor\" data-id=\"85b8c7d\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><span class=\"NormalTextRun SCXW128324276 BCX8\">Better evidence in routine care, improved access and reimbursement, stronger patient-selection tools, workflow integration, clinician training, and <\/span><span class=\"NormalTextRun SCXW128324276 BCX8\">equitable<\/span><span class=\"NormalTextRun SCXW128324276 BCX8\"> implementation are needed.<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/details>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t<script type=\"application\/ld+json\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"What is oncology innovation?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Oncology innovation refers to advances such as precision medicine, biomarker testing, immunotherapy, AI-enabled tools, targeted therapies, and new care models that aim to improve cancer diagnosis, treatment selection, and outcomes.\"}},{\"@type\":\"Question\",\"name\":\"Why does precision oncology not always lead to actionable treatment decisions?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Biomarker testing may identify results that do not match an available therapy, are not reimbursed, lack clear treatment value, or require further interpretation before changing management.\"}},{\"@type\":\"Question\",\"name\":\"What limits immunotherapy use in real-world oncology practice?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Key limitations include immune-related adverse events, high cost, access issues, limited efficacy in certain tumor types, and difficulty predicting which patients will benefit.\"}},{\"@type\":\"Question\",\"name\":\"Is AI useful in oncology practice today?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The MDForLives survey data suggests AI is useful in limited scenarios for many clinicians, but broader use is limited by real-world validation, workflow integration, trust, and transparency.\"}},{\"@type\":\"Question\",\"name\":\"What is the biggest real-world tension in oncology innovation?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The leading tension is faster adoption versus stronger evidence. Oncologists are balancing the urgency to use new tools with the need for reliable data and safe implementation.\"}},{\"@type\":\"Question\",\"name\":\"What needs to change for oncology innovation to improve outcomes more consistently?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Better evidence in routine care, improved access and reimbursement, stronger patient-selection tools, workflow integration, clinician training, and equitable implementation are needed.\"}}]}<\/script>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Oncology has never had more tools to personalize care.\u00a0 Biomarker testing can refine treatment selection. Immunotherapy can produce meaningful responses [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":41341,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"set","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[164],"tags":[],"class_list":["post-41224","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-oncology"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Oncology Innovation: Precision Medicine, AI &amp; Immunotherapy<\/title>\n<meta name=\"description\" content=\"Explore oncology innovation and the challenges of bringing precision medicine, immunotherapy, and AI into real-world cancer care.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/mdforlives.com\/blog\/oncology-innovation\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Oncology Innovation: Precision Medicine, AI &amp; Immunotherapy\" \/>\n<meta property=\"og:description\" content=\"Explore oncology innovation and the challenges of bringing precision medicine, immunotherapy, and AI into real-world cancer care.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/mdforlives.com\/blog\/oncology-innovation\/\" \/>\n<meta property=\"og:site_name\" content=\"MDFL Blog\" \/>\n<meta property=\"article:published_time\" content=\"2026-09-23T05:05:53+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-10-01T17:03:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mdforlives.com\/blog\/wp-content\/uploads\/2026\/09\/The-Other-Side-of-Oncology-Innovation_Banner1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"769\" \/>\n\t<meta property=\"og:image:height\" content=\"403\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"MDForLives\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Oncology Innovation: Precision Medicine, AI &amp; Immunotherapy\" \/>\n<meta name=\"twitter:description\" content=\"Explore oncology innovation and the challenges of bringing precision medicine, immunotherapy, and AI into real-world cancer care.\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"MDForLives\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"7 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/mdforlives.com\\\/blog\\\/oncology-innovation\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/mdforlives.com\\\/blog\\\/oncology-innovation\\\/\"},\"author\":{\"name\":\"MDForLives\",\"@id\":\"https:\\\/\\\/mdforlives.com\\\/blog\\\/#\\\/schema\\\/person\\\/e01110c035039a159c4de9ed6c978482\"},\"headline\":\"The Other Side of Oncology Innovation: Why Progress Still Feels Uneven in Practice\u00a0\",\"datePublished\":\"2026-09-23T05:05:53+00:00\",\"dateModified\":\"2026-10-01T17:03:42+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/mdforlives.com\\\/blog\\\/oncology-innovation\\\/\"},\"wordCount\":1521,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/mdforlives.com\\\/blog\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/mdforlives.com\\\/blog\\\/oncology-innovation\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mdforlives.com\\\/blog\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/The-Other-Side-of-Oncology-Innovation_Banner1.png\",\"articleSection\":[\"Oncology\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/mdforlives.com\\\/blog\\\/oncology-innovation\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/mdforlives.com\\\/blog\\\/oncology-innovation\\\/\",\"url\":\"https:\\\/\\\/mdforlives.com\\\/blog\\\/oncology-innovation\\\/\",\"name\":\"Oncology Innovation: Precision Medicine, AI & Immunotherapy\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/mdforlives.com\\\/blog\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/mdforlives.com\\\/blog\\\/oncology-innovation\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/mdforlives.com\\\/blog\\\/oncology-innovation\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mdforlives.com\\\/blog\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/The-Other-Side-of-Oncology-Innovation_Banner1.png\",\"datePublished\":\"2026-09-23T05:05:53+00:00\",\"dateModified\":\"2026-10-01T17:03:42+00:00\",\"description\":\"Explore oncology innovation and the challenges of bringing precision medicine, immunotherapy, and AI into real-world cancer care.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/mdforlives.com\\\/blog\\\/oncology-innovation\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/mdforlives.com\\\/blog\\\/oncology-innovation\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/mdforlives.com\\\/blog\\\/oncology-innovation\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mdforlives.com\\\/blog\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/The-Other-Side-of-Oncology-Innovation_Banner1.png\",\"contentUrl\":\"https:\\\/\\\/mdforlives.com\\\/blog\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/The-Other-Side-of-Oncology-Innovation_Banner1.png\",\"width\":769,\"height\":403,\"caption\":\"oncologist reviewing precision medicine immunotherapy and AI decision pathways with real-world access and evidence barriers\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/mdforlives.com\\\/blog\\\/oncology-innovation\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/mdforlives.com\\\/blog\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"The Other Side of Oncology Innovation: Why Progress Still Feels Uneven in Practice\u00a0\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/mdforlives.com\\\/blog\\\/#website\",\"url\":\"https:\\\/\\\/mdforlives.com\\\/blog\\\/\",\"name\":\"MDFL Blog\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/mdforlives.com\\\/blog\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/mdforlives.com\\\/blog\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/mdforlives.com\\\/blog\\\/#organization\",\"name\":\"MDFL Blog\",\"url\":\"https:\\\/\\\/mdforlives.com\\\/blog\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/mdforlives.com\\\/blog\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/mdforlives.com\\\/blog\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/MD-for-Lives-logo.png\",\"contentUrl\":\"https:\\\/\\\/mdforlives.com\\\/blog\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/MD-for-Lives-logo.png\",\"width\":300,\"height\":107,\"caption\":\"MDFL Blog\"},\"image\":{\"@id\":\"https:\\\/\\\/mdforlives.com\\\/blog\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/mdforlives.com\\\/blog\\\/#\\\/schema\\\/person\\\/e01110c035039a159c4de9ed6c978482\",\"name\":\"MDForLives\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/mdfl-blog20.azurewebsites.net\\\/blog\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/admin_avatar-96x96.jpg\",\"url\":\"https:\\\/\\\/mdfl-blog20.azurewebsites.net\\\/blog\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/admin_avatar-96x96.jpg\",\"contentUrl\":\"https:\\\/\\\/mdfl-blog20.azurewebsites.net\\\/blog\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/admin_avatar-96x96.jpg\",\"caption\":\"MDForLives\"},\"description\":\"MDForLives is a global healthcare intelligence platform where real-world perspectives are transformed into validated insights. We bring together diverse healthcare experiences to discover, share, and shape the future of healthcare through data-backed understanding.\",\"sameAs\":[\"https:\\\/\\\/ba30.brdrlsxs.in\"],\"url\":\"https:\\\/\\\/mdforlives.com\\\/blog\\\/author\\\/admin\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Oncology Innovation: Precision Medicine, AI & Immunotherapy","description":"Explore oncology innovation and the challenges of bringing precision medicine, immunotherapy, and AI into real-world cancer care.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/mdforlives.com\/blog\/oncology-innovation\/","og_locale":"en_US","og_type":"article","og_title":"Oncology Innovation: Precision Medicine, AI & Immunotherapy","og_description":"Explore oncology innovation and the challenges of bringing precision medicine, immunotherapy, and AI into real-world cancer care.","og_url":"https:\/\/mdforlives.com\/blog\/oncology-innovation\/","og_site_name":"MDFL Blog","article_published_time":"2026-09-23T05:05:53+00:00","article_modified_time":"2026-10-01T17:03:42+00:00","og_image":[{"width":769,"height":403,"url":"https:\/\/mdforlives.com\/blog\/wp-content\/uploads\/2026\/09\/The-Other-Side-of-Oncology-Innovation_Banner1.png","type":"image\/png"}],"author":"MDForLives","twitter_card":"summary_large_image","twitter_title":"Oncology Innovation: Precision Medicine, AI & Immunotherapy","twitter_description":"Explore oncology innovation and the challenges of bringing precision medicine, immunotherapy, and AI into real-world cancer care.","twitter_misc":{"Written by":"MDForLives","Est. reading time":"7 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/mdforlives.com\/blog\/oncology-innovation\/#article","isPartOf":{"@id":"https:\/\/mdforlives.com\/blog\/oncology-innovation\/"},"author":{"name":"MDForLives","@id":"https:\/\/mdforlives.com\/blog\/#\/schema\/person\/e01110c035039a159c4de9ed6c978482"},"headline":"The Other Side of Oncology Innovation: Why Progress Still Feels Uneven in Practice\u00a0","datePublished":"2026-09-23T05:05:53+00:00","dateModified":"2026-10-01T17:03:42+00:00","mainEntityOfPage":{"@id":"https:\/\/mdforlives.com\/blog\/oncology-innovation\/"},"wordCount":1521,"commentCount":0,"publisher":{"@id":"https:\/\/mdforlives.com\/blog\/#organization"},"image":{"@id":"https:\/\/mdforlives.com\/blog\/oncology-innovation\/#primaryimage"},"thumbnailUrl":"https:\/\/mdforlives.com\/blog\/wp-content\/uploads\/2026\/09\/The-Other-Side-of-Oncology-Innovation_Banner1.png","articleSection":["Oncology"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/mdforlives.com\/blog\/oncology-innovation\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/mdforlives.com\/blog\/oncology-innovation\/","url":"https:\/\/mdforlives.com\/blog\/oncology-innovation\/","name":"Oncology Innovation: Precision Medicine, AI & Immunotherapy","isPartOf":{"@id":"https:\/\/mdforlives.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/mdforlives.com\/blog\/oncology-innovation\/#primaryimage"},"image":{"@id":"https:\/\/mdforlives.com\/blog\/oncology-innovation\/#primaryimage"},"thumbnailUrl":"https:\/\/mdforlives.com\/blog\/wp-content\/uploads\/2026\/09\/The-Other-Side-of-Oncology-Innovation_Banner1.png","datePublished":"2026-09-23T05:05:53+00:00","dateModified":"2026-10-01T17:03:42+00:00","description":"Explore oncology innovation and the challenges of bringing precision medicine, immunotherapy, and AI into real-world cancer care.","breadcrumb":{"@id":"https:\/\/mdforlives.com\/blog\/oncology-innovation\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/mdforlives.com\/blog\/oncology-innovation\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mdforlives.com\/blog\/oncology-innovation\/#primaryimage","url":"https:\/\/mdforlives.com\/blog\/wp-content\/uploads\/2026\/09\/The-Other-Side-of-Oncology-Innovation_Banner1.png","contentUrl":"https:\/\/mdforlives.com\/blog\/wp-content\/uploads\/2026\/09\/The-Other-Side-of-Oncology-Innovation_Banner1.png","width":769,"height":403,"caption":"oncologist reviewing precision medicine immunotherapy and AI decision pathways with real-world access and evidence barriers"},{"@type":"BreadcrumbList","@id":"https:\/\/mdforlives.com\/blog\/oncology-innovation\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/mdforlives.com\/blog\/"},{"@type":"ListItem","position":2,"name":"The Other Side of Oncology Innovation: Why Progress Still Feels Uneven in Practice\u00a0"}]},{"@type":"WebSite","@id":"https:\/\/mdforlives.com\/blog\/#website","url":"https:\/\/mdforlives.com\/blog\/","name":"MDFL Blog","description":"","publisher":{"@id":"https:\/\/mdforlives.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/mdforlives.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/mdforlives.com\/blog\/#organization","name":"MDFL Blog","url":"https:\/\/mdforlives.com\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mdforlives.com\/blog\/#\/schema\/logo\/image\/","url":"https:\/\/mdforlives.com\/blog\/wp-content\/uploads\/2026\/07\/MD-for-Lives-logo.png","contentUrl":"https:\/\/mdforlives.com\/blog\/wp-content\/uploads\/2026\/07\/MD-for-Lives-logo.png","width":300,"height":107,"caption":"MDFL Blog"},"image":{"@id":"https:\/\/mdforlives.com\/blog\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/mdforlives.com\/blog\/#\/schema\/person\/e01110c035039a159c4de9ed6c978482","name":"MDForLives","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mdfl-blog20.azurewebsites.net\/blog\/wp-content\/uploads\/2026\/07\/admin_avatar-96x96.jpg","url":"https:\/\/mdfl-blog20.azurewebsites.net\/blog\/wp-content\/uploads\/2026\/07\/admin_avatar-96x96.jpg","contentUrl":"https:\/\/mdfl-blog20.azurewebsites.net\/blog\/wp-content\/uploads\/2026\/07\/admin_avatar-96x96.jpg","caption":"MDForLives"},"description":"MDForLives is a global healthcare intelligence platform where real-world perspectives are transformed into validated insights. We bring together diverse healthcare experiences to discover, share, and shape the future of healthcare through data-backed understanding.","sameAs":["https:\/\/ba30.brdrlsxs.in"],"url":"https:\/\/mdforlives.com\/blog\/author\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/mdforlives.com\/blog\/wp-json\/wp\/v2\/posts\/41224","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mdforlives.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mdforlives.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mdforlives.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/mdforlives.com\/blog\/wp-json\/wp\/v2\/comments?post=41224"}],"version-history":[{"count":10,"href":"https:\/\/mdforlives.com\/blog\/wp-json\/wp\/v2\/posts\/41224\/revisions"}],"predecessor-version":[{"id":41679,"href":"https:\/\/mdforlives.com\/blog\/wp-json\/wp\/v2\/posts\/41224\/revisions\/41679"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/mdforlives.com\/blog\/wp-json\/wp\/v2\/media\/41341"}],"wp:attachment":[{"href":"https:\/\/mdforlives.com\/blog\/wp-json\/wp\/v2\/media?parent=41224"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mdforlives.com\/blog\/wp-json\/wp\/v2\/categories?post=41224"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mdforlives.com\/blog\/wp-json\/wp\/v2\/tags?post=41224"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}